Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans

Biology of Reproduction

Volumn 56, Issue 1, 1997, Pages 67-72

  Tao, Y X ^b   Bao, S ^b   Ackermann, D M ^c   Lei, Z M ^b   Rao, Ch V ^a,b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c Norton Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE;

ARTICLE; CANCER CELL; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; RECEPTOR GENE; STROMA; TARGET CELL;

AGED; BLOTTING, NORTHERN; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, LH; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031029517     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod56.1.67     Document Type: Article

References (43)

1. Garnick MB. The dilemmas of prostate cancer. Sci Am April 1994; 72-81.
2. Wilding G. The importance of steroid hormones in prostate cancer. Cancer Surv 1992; 14:113-130.
3. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr Rev 1987; 8:338-362.
4. Luke MC, Coffey DS. The male sex accessory tissues: structure, androgen action and physiology. In: Knobil E, Neill JD (eds.), The Physiology of Reproduction, 2nd ed. New York: Raven Press; 1994: 1435-1487.
5. Tao YX, Lei ZM, Woodworth SH, Rao ChV. Novel expression of luteinizing hormone/chorionic gonadotropin receptor gene in rat prostates. Mol Cell Endocrinol 1995; 111:R9-R12.
6. Reiter E, McNamara M, Closset J, Hennen G. Expression and functionality of luteinizing hormone/chorionic gonadotropin receptor in the rat prostate. Endocrinology 1995; 136:917-923.
7. Mostofi FK, Davis CJ, Sesterhenn IA. Pathology of carcinoma of the prostate. Cancer 1992; 70(suppl):235-253.
8. Tao YX, Lei ZM, Hoffman GE, Rao ChV. Human intermediate trophoblasts express chorionic gonadotropin/luteinizing hormone receptor gene. Biol Reprod 1995; 53:899-904.
9. Reshef E, Lei ZM, Rao ChV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnanl human uterus, human placenta, fetal membranes and decidua. J Clin Endocrinol & Metab 1990; 70:421-430.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning - A Laboratory Manual, ed 2. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory; 1989: 7.39-7.57.
11. Masiakowski R, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10: 7895-7903.
12. Laborda J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 1991; 19:3998.
13. Kornyei J, Lei ZM, Rao ChV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol Reprod 1993; 49:1149-1157.
14. Toth P, Li X, Rao ChV, Lincoln SR, Sanfilippo JS, Spinnato JA, Yussman MA. Expression of functional human chorionic gonadotropin/ human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol & Metab 1994; 79:307-315.
15. Singh M, Zuo J, Li X, Ambrus G, Lei ZM, Yussman MA, Sanfilippo JS, Rao ChV. The decreased expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human uterine leiomyomas. Biol Reprod 1995; 53:591-597.
16. Han SW, Lei ZM, Rao ChV. Upregulation of cyclooxygenase-2 gene expression by chorionic gonadotropin in mucosal cells from human fallopian tubes. Endocrinology 1996; 137:2929-2937.
17. Lei ZM, Toth P, Rao ChV, Pridham D. Novel co-expression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand, hCG, in human fallopian tubes. J Clin Endocrinol & Metab 1993; 77:863-872.
18. Rao ChV, Li X, Toth P, Lei ZM, Cook VD. Novel expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human umbilical cords. J Clin Endocrinol & Metab 1993; 77:1706-1714.
19. Rao ChV. The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/ human chorionic gonadotropin receptors in nongonadal tissues. J Physiol Pharmacol 1996; 47:41-53.
20. Rui H, Purvis K. Hormonal control of prostate function. Scan J Urol Nephrol Suppl 1988; 107:32-38.
21. Davies P, Eaton CL. Regulation of prostate growth. J Endocrinol 1991; 131:5-17.
22. Steiner MS. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol 1995; 153:1085-1096.
23. Reiter E, Bonnet P, Sente B, Dombrowicz D, de Leval J, Closset J, Hennen G. Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol Cell Endocrinol 1992; 88:77-87.
24. Reubi JC, Waser B, Schaer J-C, Markwalder R. Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol & Metab 1995; 80:2806-2814.
25. Lapthom AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature 1994; 369:455-461.
26. Eta E, Ambrus G, Rao ChV. Direct regulation of human myometrial contractions by human chorionic gonadotropin. J Clin Endocrinol & Metab 1994; 79:1582-1586.
27. Ambrus G, Rao ChV. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology 1994; 135:2772-2779.
28. Han SW, Lei ZM, Rao ChV. Upregulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology 1996; 137: 1791-1797.
29. Chegini N, Lei ZM, Rao ChV, Hansel W. Cellular distribution and cycle phase dependency of gonadotropin and eicosanoids binding sites in bovine corpora lutea. Biol Reprod 1991; 45:506-513.
30. Masai M, Sumiya H, Akimoto S, Yatani R, Chang C, Liao S, Shimazaki J. Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 1990; 17:293-300.
31. Miyamoto KK, McSherry SA, Dent GA, Sar M, Wilson EM, French FS, Sharief Y, Mohler JL. Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J Urol 1993; 149:1015-1019.
32. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu MT, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983; 43:1908-1918.
33. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978; 21:274-281.
34. Zhang F-P, Markkula M, Toppari J, Huhtaniemi I. Novel expression of luteinizing hormone subunit genes in the rat testis. Endocrinology 1995; 136:2904-2912.
35. Madersbacher S, Kratzik C, Gerth R, Dirnhofer S, Berger P. Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of testicular cancer patients: insights into the vivo hCG secretion pattern. Cancer Res 1994; 54:5096-5100.
36. Naughton MA, Merrill DA, McManus LM, Fink LM, Berman E, White MJ, Martinez-Hernandez A. Localization of the β chain of human chorionic gonadotropin on human tumor cells and placental cells. Cancer Res 1975; 35:1887-1890.
37. Reiter E, McNamara EM, Hennuy B, Sente B, Thunus S, Hennen G. Ubiquitous co-expression of LH subunits and LH receptor in rat organs. In: Program of the 77th annual meeting of The Endocrine Society; 1995; Washington, DC. Abstract P3-396.
38. Winters SJ, Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol & Metab 1982; 55:560-565.
39. Davidson JM, Chen JJ, Crapo L, Gray GD, Greenleaf WJ, Catania JA. Hormonal changes and sexual function in aging men. J Clin Endocrinol & Metab 1983; 57:71-77.
40. Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol & Metab 1987; 65:1118-1126.
41. Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, Veldhuis JD. Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling - a clinical research center study. J Clin Endocrinol & Metab 1995; 80:3025-3031.
42. Levine AC. Management of benign prostatic hyperplasia: the role of gonadotropin-releasing hormone analogues and summation. J Clin Endocrinol & Metab 1995; 80:753-756.
43. Kadar T, Ben-David M, Pontes JE, Fekete M, Schally AV. Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer. Prostate 1988; 12:299-307.